Vimarsana
Biggest News Aggregation in the World

Page 10 - Presentation Details News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presentation Details. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presentation Details Today - Breaking & Trending Today

BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023 - Vimarsana News

BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023

Program updates include new data for investigational CAR-T and ex-vivo T cell therapies, a novel ADC, a FixVac off-the-shelf mRNA cancer vaccine, and a bi-specific antibody New data from BioNTech’s...

BioNTech to Present Multiple Program Updates Across - Vimarsana News

BioNTech to Present Multiple Program Updates Across

Program updates include new data for investigational CAR-T and ex-vivo T cell therapies, a novel ADC, a FixVac off-the-shelf mRNA cancer vaccine, and a...

2023-10-11 | NDAQ:ELTX | Press Release | Elicio Therapeutics Inc - Vimarsana News

2023-10-11 | NDAQ:ELTX | Press Release | Elicio Therapeutics Inc

(2023-10-11 | NDAQ:ELTX) Elicio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer's (SITC 2023) Annual Meeting

GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference - Vimarsana News

GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference

20.09.2023 - Preclinical Data for GEO-CM02 Demonstrates Single-Dose ProtectionAgainst Multiple SARS-CoV-2 Variants ATLANTA, GA, Sept. 20, 2023 (GLOBE NEWSWIRE) - via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing ... Seite 1

Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Vimarsana News

Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients...